WHO public report for the kit performance evaluation of YF MAC-HD 1.0 assay to detect IgM to yellow fever virus in the context of surveillance

Overview

On a need’s basis, the Immunization Analysis and Insights, Vaccine Preventable Diseases (VPD) Surveillance and Risk Assessment Team of the World Health Organization (WHO) posts expression of interest (EOI) calls, inviting manufacturers of specified technologies (in vitro diagnostics also known as IVDs) to participate in a WHO product evaluation. The focus is on IVDs that are used by WHO’s laboratory networks undertaking surveillance for certain VPDs.

The WHO Kit Performance Evaluation Programme outcomes generate information on product suitability for WHO’s laboratory networks undertaking the surveillance of VPDs and are reported in public reports.

The current report outlines the outcome of such evaluation programme undertaken for the YF MAC-HD 1.0 assay (manufactured by ATCC) to detect IgM to Yellow fever virus in the context of surveillance.

This a the first commercially available IgM antibody capture enzyme linked immunosorbent assay (MAC-ELISA) serology assay recommended by WHO for the detection of yellow fever in the context of surveillance.

Read more about ATCC’s YF MAC-HD 1.0 assay kit performance in the attached public report.